Dihydrocaffeic Acid

Dihydrocaffeic Acid

SCHEMBL15520737

NCc1ccc(O)c(O)c1.O=C(O)CCc1ccc(O)c(O)c1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
MAPT P10636 4/20 0.56
TDP1 Q9NUW8 4/20 0.56
ALOX15 P16050 4/20 0.56
RECQL P46063 3/20 0.56
HIF1A Q16665 3/20 0.56
HSD17B10 Q99714 3/20 0.56
ADRA2A P08913 2/20 0.56
DRD2 P14416 2/20 0.56
DRD1 P21728 2/20 0.56
DRD4 P21917 2/20 0.56
DRD5 P21918 2/20 0.56
SLC6A2 P23975 2/20 0.56
APEX1 P27695 2/20 0.56
MAPK1 P28482 2/20 0.56
DRD3 P35462 2/20 0.56
THPO P40225 2/20 0.56
SLC6A3 Q01959 2/20 0.56
ALDH1A1 P00352 2/20 0.56
PTGS1 P23219 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydrocaffeic Acid SCHEMBL245530 0.91 IAPP (0.65) KDM4EMAPTTDP1ALOX15RECQL
Dihydrocaffeic Acid SCHEMBL7058919 0.91 IAPP (0.65) KDM4EMAPTTDP1ALOX15RECQL
Dihydrocaffeic Acid SCHEMBL29351390 0.91 IAPP (0.65) KDM4EMAPTTDP1ALOX15RECQL
Dihydrocaffeic Acid SCHEMBL175650 0.85 KDM4E (0.55) KDM4EMAPTTDP1ALOX15RECQL
Dihydrocaffeic Acid SCHEMBL31017610 0.84 IAPP (0.57) KDM4EMAPTTDP1ALOX15RECQL
Acetic Acid SCHEMBL27634531 0.82 KDM4E (0.58) KDM4EMAPTTDP1ALOX15RECQL
SCHEMBL110644 0.81 KDM4E (0.67) KDM4EMAPTTDP1ALOX15RECQL
SCHEMBL29359577 0.81 KDM4E (0.67) KDM4EMAPTTDP1ALOX15RECQL
SCHEMBL31273986 0.80 KEAP1 (0.61) MAPK1SLC6A3CYP2D6ADRA1ATSHR
SCHEMBL18788836 0.80 IGF1R (0.67) KDM4EMAPTTDP1ALOX15HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2527315-B1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease PROTEOTECH INC (US) 2014-03-19 EP disclosed